Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 17, 2026.

Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections

Adèle Sakr, Fabienne Brégeon, Jean-Louis Mège and 2 more

Frontiers in Microbiology · 2018 · Review

doi:10.3389/fmicb.2018.02419

Abstract

Up to 30 % of the human population are asymptomatically and permanently colonized with nasal Staphylococcus aureus. To successfully colonize human nares, S. aureus needs to establish solid interactions with human nasal epithelial cells and overcome host defense mechanisms. However, some factors like bacterial interactions in the human nose can influence S. aureus colonization and sometimes prevent colonization. On the other hand, certain host characteristics and environmental factors can predispose to colonization. Nasal colonization can cause opportunistic and sometimes life-threatening infections such as surgical site infections or other infections in non-surgical patients that increase morbidity, mortality as well as healthcare costs.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 17, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Staphylococcus aureus is both a human skin and mucosae commensal but also a frequent cause of serious infections with high morbidity, mortality, and healthcare-associated costs. The most frequent carriage site is the vestibulum nasi (or anterior nares), which serves as reservoir for the spread of the pathogen. This bacteria can establish solid interactions with nasal epithelial cells via various proteins and many cell surface components, thus transforming into persistent carriage. S. aureus colonizes the anterior nares of 20% to 80% of the human population. Nasal carriage has been shown to play a key role in the pathogenesis of S. aureus infections in patients undergoing surgery, dialysis, and in intensive care unit (ICU) patients, with higher infection risks in persistent carriers.

Previously published reviews on S. aureus carriage have usually focused independently on colonization or infections, or have issued a specific underlying condition or surgery. Here, we will full review recent advances in nasal microbiota composition and interspecies interactions, epidemiology, and risk factors for S. aureus colonization as well as the link between nasal carriage and infections both in community and nosocomial context.

Nasal Microbiota and Interactions Between Bacteria

The adult nasal microbiota differs between individuals, but species belonging to Corynebacterium, Propionibacterium, and Staphylococcus genera are the most abundant bacteria. In a study conducted on the nasal microbiota of 178 adults, 88.2% were Corynebacterium carriers, 83.7% Propionibacterium acnes carriers, and 90.4% Staphylococcus epidermidis carriers. Proportional abundance varied considerably between individuals.

The health status may influence the nasal microbiota and vice versa. In a study involving healthy and hospitalized individuals, healthy adults harbored nares microbiota dominated by Actinobacteria (mainly Propionibacterium and Corynebacterium spp.) whereas patients microbiota were dominated by S. aureus and S. epidermidis. S. aureus colonization was negatively associated with the presence of other bacteria including S. epidermidis. Such counterweight effect between bacteria could be the result of interdependent activation-inhibition mechanisms as reviewed by. In fact, some bacterial species are capable of secreting anti-staphylococcal molecules modulating S. aureus abundance (Figure 1). For instance, in vitro production of H2O2 by Streptococcus pneumoniae can be bactericidal on S. aureus. Recently, an in vitro and human study demonstrated that lugdunin, a non-ribosomal synthesized bioactive compound produced by Staphylococcus lugdunensis, can prevent S. aureus nasal colonization via a bactericidal effect.

In some cases, the bacteria-secreted molecules can modify S. aureus adhesion properties. Some types of S. epidermidis seem to be capable of synthetizing the serine protease Esp that eliminates nasal S. aureus in healthy humans, probably by degrading staphylococcal surface proteins and human receptors critical for host–pathogen interaction. As well, Propionibacterium species produce coproporphyrin III, a porphyrin metabolite that induces S. aureus aggregation which influences nasal colonization.

Corynebacterium species are suggested to antagonize S. aureus by human cell binding competition mechanisms. In 156 healthy volunteers, observed a 71% total eradication rate of nasal S. aureus after performing up to 15 inoculations of a Corynebacterium sp. strain to the nares of S. aureus carriers.

Intra-species competition has also been described. In a cross-sectional clinical study, it was suggested that methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) compete for colonization, MSSA being protective with regard to MRSA carriage. On the other hand, pre-existing nasal carriage with S. aureus could predispose adult patients to further staphylococcal colonization.

Spread and Transmission of S. aureus

Staphylococcus aureus can be found in different body sites like the skin, rectum, vagina, gastrointestinal tract and axilla, the anterior nares appearing as the main reservoir. From a cutaneous commensal site, S. aureus can enter in contact with the nasal mucosa, then interact with epithelial cell ligands such as loricrin and cytokeratin 10 (K10) (Table 1). Once the host’s defenses are overcome, S. aureus can propagate into the anterior nares so that the host becomes an S. aureus nasal carrier. In human, nasal colonization may begin within the first days of life. This has been demonstrated in a cohort study evaluating nasal carriage of S. aureus in 100 pairs of infant–mother for a period of 6 months following delivery. The carriage rate in the first 8 weeks of life was around 40–50%, thereafter it dropped to 21% at 6 months. In addition, this study found a nasal carriage concordance in 68% of infant–mother pairs attesting the role of environmental factors in S. aureus carriage. Another study found identical strains in 80% of infant–mother pairs. In 90% of these newborns, the source of S. aureus was the maternal nasal strain (; Figure 2).

After birth, hands are the main vector for S. aureus transmission from surfaces to the nose. The hypothesis of a link between hand and nose S. aureus carriage is supported by the double blind randomized placebo controlled trial from, who demonstrated that nasal decolonization with mupirocin applied to health-care workers resulted in a decrease of nose and hand carriage. In a cohort study including outpatients and healthy hospital employees, nasal carriage was evaluated by a single or several swabs. Participants completed a questionnaire about their nose picking behavior, a positive correlation between this habit and nasal carriage of S. aureus was found. However, it is unknown whether nose-picking patients were more frequently colonized at extra nasal sites.

Studies realized in individuals living in the same households have revealed that these people tend to carry genetically similar strains in their nares suggesting horizontal transmission. Multisite MRSA carriage increases the risk for nasal MRSA colonization.

In spite infrequent, airborne transmission is another possible route of S. aureus dissemination and may play a role in hospital outbreaks.

During viral upper respiratory infections, the risk of disseminating endogenous S. aureus in the air increases and infection outbreaks may occur. In 1996, an MRSA outbreak involving 8 of 43 patients occurred in a surgical ICU of a university hospital in the United States. Investigations of the cause concluded that a single physician was the source of this outbreak; he was a nasal carrier of MRSA and suffered an upper respiratory infection. To assess airborne dispersal of S. aureus, the authors completed their findings by an experimental clinical test on this physician and showed that transmission of the bacterium increased by 40-fold when he was infected by a rhinovirus infection than when he was not. The use of a mask significantly reduced dispersal (P = 0.015).

Healthcare workers who are asymptomatic nasal carriers can sometimes be the source of MRSA outbreaks. On the other hand, in nonoutbreak situations and in presence of control measures, healthcare workers are infrequently sources of transmission of S. aureus.

Mobile phones of healthcare workers may be a reservoir of S. aureus. A recent study evaluated incidence of bacterial contamination of mobile phones belonging to medical staff working in the operating room. Seventy two healthcare professionals took bacterial cultures from their phones, anterior nares, and hands. The results revealed that 31 staff had S. aureus isolated from their nares, 8 from their mobile phones, and 4 from their hands. Genotyping confirmed that 7/8 of the mobile phones strains were identical to the ones isolated from the nares.

Mechanisms of Colonization

The vestibulum nasi or anterior part of the nares is lined by a stratified, keratinized nonciliated squamous epithelium, whereas the rest of the nasal cavity, that is, its inner part is lined with a ciliated columnar epithelium.

Both epithelia have been described as habitats for S. aureus as it will be developed in this section. Intracellular localization in nasal tissue from healthy volunteers was also described. For a successful colonization, S. aureus expresses adhesive molecules, fundamental for the establishment of interactions with human cell surface components, as it was demonstrated in vitro and in vivo (;; Figure 3). Major ligands interactions are listed in Table 1.

Interaction Between S. aureus and the Squamous Epithelium of the Anterior Nares

The vestibulum nasi is lined by skin (; Vuyk and Watts, 2006). The uppermost layer of the epidermis is the stratum corneum or cornified layer. This layer contains keratinocytes that express proteins, such as loricrin, cytokeratin 10 (K10), involucrin, filaggrin, and other proteins.

Clumping factor B (ClfB) and iron-regulated surface determinant A (IsdA) are staphylococcal surface proteins that can adhere to cornified envelope proteins and favor nasal colonization as it will be developed in this section.

Recently, demonstrated that loricrin, the most abundant protein in the cornified envelope, was the major target ligand for ClfB during S. aureus nasal colonization. Nasal colonization by a ClfB+ S. aureus strain was reduced by 80% in loricrin-deficient mice compared to wild-type mice. ClfB has also been shown to interact with cytokeratin 10, cytokeratin 8, and fibrinogen (; Table 1). The role of ClfB in the adherence of S. aureus to the nasal epithelium has been studied in vitro, in animal models, and in human studies.

demonstrated that mutant strains of S. aureus deficient in ClfB resulted in a reduced nasal colonization in both mice and rats, as compared to the wild-type strain (ClfB+). In human, the mutant strain ClfB- of S. aureus has been reported to be cleared faster than the wild-type strain (median 3 ± 1 vs. 7 ± 4 days, p = 0.006), whereas the wild-type strain persisted for 28 days after inoculation.

IsdA also plays a role in the adherence of S. aureus to nasal cells as demonstrated in vitro and in vivo. Mutation in IsdA gene reduced the ability of the bacteria to bind human nasal cells in vitro and to colonize the anterior nares in cotton rats. This surface protein has also been shown to bind to fibrinogen and fibronectin. The role of IsdA in nasal colonization has not been clearly demonstrated in human studies yet.

Other S. aureus surface proteins, such as surface protein G (SasG), SasX, and the serine-aspartate repeat proteins SdrC and SdrD may also serve as ligands to the epithelial cells. Desmoglein 1 was identified as a host ligand for SdrD. Their roles in humans have not been tested yet.

Interaction in the Inner Nasal Cavity

Apart from the vestibulum nasi, the inner part of the nasal cavity constitutes another ecological niche for S. aureus. The staphylococcal nonprotein adhesin, named cell wall teichoic acid (WTA) is considered as an important factor for the colonization process. In an in vivo study, WTA-deficient S. aureus mutants could not adhere to nasal cells and were unable to colonize cotton rat nares compared to wild type control strains.

In a study combining in vitro and in vivo assessments, studied the molecular details of WTA adhesion to nasal cells. They first discovered that SREC-1 (a member of the F-type scavenger receptor) was expressed on epithelial cells in the inner nasal cavity of human and cotton rats. The authors further reported that SREC-1 interacted with WTA and confirmed these findings in infected cotton rats pretreated with antiSREC-1 antibody. A significant decrease in colonization was observed 8 h and 6 days after inoculation in the group receiving antiSREC-1 antibody, as compared to the controls. In agreement, previously demonstrated the role of WTA in the initial stages of S. aureus colonization.

Intracellular Localization of S. aureus

Intracellular localization of S. aureus in the nasal tissue has been described using techniques including immunohistochemical analysis, hematoxylin, and Eosin stains. Epithelial cells, endothelial cells, and inflammatory cells, especially mast cells have been described as habitats for intracellular S. aureus (ICSA). Using skin biopsies from the vestibulum nasi of randomly selected healthy participants, detected intracellular S. aureus in the stratum spinosum, one of the layers forming the epidermis. Intracellular localization of S. aureus has been reported both in patients with rhinosinusitis and healthy volunteers. In the control population from the study of, 38% had ICSA. However, in the absence of large scale population study, the true prevalence of ICSA in healthy individuals remains to determine.

Intracellular localization of S. aureus seems to protect the bacteria from host defense mechanisms and favor antimicrobial agents’ failure, as it was demonstrated in a recent study evaluating systemic and topical antibiotics. Using a cell model of S. aureus nasal epithelium evasion, found that most of the decolonizing agents, including mupirocin, exhibited weak activity against ICSA. Elimination of ICSA was also studied in a mouse model using vancomycin. In this study, intracellular bacteria were able to establish infection even in the presence of this antibiotic, whereas planktonic bacteria were eliminated by vancomycin and did not cause infection. The intracellular residency of S. aureus could explain re-colonization and failure in decolonization observed in some healthy carriers, and the recurrence of infections observed in patients with chronic rhinosinusitis.

Immune System and S. aureus Colonization

Our knowledge in terms of host response during S. aureus nasal colonization is still limited as compared to immune response in invasive S. aureus infection. The association between the host immune system and S. aureus nasal carriage has been recently reviewed by. The presence of S. aureus in the nares seems to induce both innate and adaptive immune system. S. aureus can otherwise overcome host defense mechanisms. The staphylococcal protein A (SpA) and the exoprotein staphylokinase could play a key role in the bacterial adaptation to the immune system and colonization process.

Innate Immune Response

Human nasal secretions have efficient natural antimicrobial activity. Indeed, they contain epithelial-cells secreted antimicrobial peptides (AMPs) contributing to the first line defense in the nose. Primary nasal epithelial cells yield AMPs such as hBD3 and RNase-7 after stimulation with cytokines (IFN-g, IL-1b, and TNF-a). Media containing S. aureus induce the expression of these AMPs less efficiently than inflammatory cytokines. Differential expression profiles of AMPs could be primary determinants for different S. aureus carriage states.

Anti-staphylococcal responses can be induced by the involvement of Toll-like receptors (TLR). Hence, the role of TLR2 has been documented in nasal S. aureus colonization. Carrier strains of S. aureus have been shown to delay the host’s immune response compared to non-carrier strains due to the delayed TLR2 expression they stimulate in nasal epithelial cells. Different polymorphisms have been found in S. aureus nasal carriers and non-carriers; they target soluble or membrane-binding molecules such as genes encoding mannose-binding lectin, glucocorticoid receptor, C-reactive protein, beta-defensin 1, TLR-9, and interleukin-4.

A study evaluating neutrophil depletion was performed in mice to determine the importance of neutrophil influx during carriage. Mice that received an antibody for neutrophil depletion had a significant increase in S. aureus colonization rate as compared to controls. This in vivo study highlights that neutrophil influx plays a role in clearance of S. aureus.

Adaptive Immune Response

As documented from serum analysis, S. aureus carriage induces an adaptive humoral immune response. Serum levels of immunoglobulin IgG and IgA specific to several staphylococcal proteins have been reported to be higher in persistent carriers than in non-carriers. But evidence that these antibodies are protective against colonization are lacking.

In a murine model of nasal colonization, clearance of S. aureus was found to be B-cell independent but T-cell mediated. The Th17 cells, a functional T-cell lineage distinct from Th1 and Th2 are known to be involved in mucosal barriers and surface pathogen clearance. They typically produce IL-17 cytokine family., ) showed that IL-17A and IL-17F deficient mice failed to clear S. aureus experimentally inoculated through nasal route; IL-17A was required for AMP expression induced by nasal colonization. In a murine model, the IL-10 family cytokine IL-22 was secreted by Th17 cells and facilitated local expression of AMPs. IL-22 also reduced the expression of staphylococcal ligands loricrin and cytokeratin 10 and thus controlled nasal colonization.

By contrast, in a human study evaluating nasal fluid inflammatory factors and nasal carriage with S. aureus, IL-17 was not detected. This was surprising and the authors suggested that IL-17 could be insoluble in nasal secretions. Low Th1 to Th17 cytokines ratio were found to be predictive of S. aureus carriage in volunteers after whole blood stimulation with S. aureus. Future human studies should be conducted to better understand the role of Th17 cytokines in nasal carriage.

Microbiology-Based Classification of Nasal Carriers

In order to confirm nasal carriage of S. aureus, samples are commonly collected using commercial dry or moistened sterile swabs, with no significant difference found between the two. The protocol of sampling is not really standardized but generally consists of rubbing the swab in the anterior nares of each nostril for approximately four rotary movements. Swabs are then analyzed to check presence of S. aureus. The two commonly used laboratory tests for the identification of S. aureus are the culture on chromogenic solid media – which is the less expensive test – and polymerase chain reaction, which is the gold standard and the most rapid technique for MRSA detection. It is important to note that chronic carriage of S. aureus may not only result from nasal colonization. Sampling extra-nasal sites like oropharynx, rectum, wounds, axilla increases MRSA detection rate in patients at risk for S. aureus nosocomial infection.

Epidemiological studies over periods varying from 12 weeks to 3 years have described three nasal carriage patterns for S. aureus among healthy volunteers swabbed several times. Persistent carriers which rates ranged from 10% to 30%, non-carriers which rates ranged from 10% to 47%, and the rest who were considered intermittent carriers. The definitions used for this classification varied from one study to another. In some studies, persistent carriers were the ones who had results of all of their swabs positive for S. aureus. Other studies defined cut-off values for carrier–index (number of positive swabs/number of total swabs for each person). However, there is no clear definition on the number of swabs that should be taken and what fraction should be positive before determining carriage state.

proposed a culture rule based on the combination of qualitative and quantitative results of two consecutive nasal culture swabs taken approximately a week apart, to predict S. aureus nasal carrier state among healthy volunteers. When both cultures are positive over 103 colony forming units (cfu) a person is classified as persistent carrier. When only one of the cultures is positive, or when both cultures are positive with a low cfu, the person is considered as an intermittent carrier. performed a study in 51 volunteers with a known carriage state, who were artificially colonized with a mixture of S. aureus strains after a decolonization treatment and followed for 22 weeks. Median nasal bacterial survival was of 4 days in noncarriers, 14 days in intermittent carriers, and more than 154 days in persistent carriers (P = 0.017). The culture swabs of persistent carriers contained more bacterial loads compared to the other groups. Serum levels of anti-staphylococcal antibodies differed between persistent and nonpersistent carriers as previously stated. The authors concluded that intermittent and noncarriers share similar characteristics, and thus suggested a reclassification of S. aureus nasal carriers into persistent carriers and “other” carriers. Persistent carriers have been shown to have higher counts of S. aureus and a higher risk of infection compared to other carriers. However, bacterial loads in persistent carriers are always variable and it is hard to determine a fixed threshold for diagnosis. Persistent carriage is more common in children than in adults, but many people change their carrier state between 10 and 20 years old. Conclusions that persistent carriers harbor the same strain for many years, and intermittent carriers appear to have changing strains have been recently the subject of controversy.

Cross-sectional studies yield a prevalence of approximately 20–30% of carriers in the general population which is a mix of persistent and intermittent carriers.

Individual Risk Factors for S. aureus Nasal Colonization

Nasal colonization depends on host factors, such as the underlying condition or diseases (Table 2). Some studies have found that nasal carriage was more frequent in human immunodeficiency virus (HIV)-infected or obese patients, compared to healthy individuals. This higher prevalence was also found among diabetic patients undergoing dialysis compared to non-diabetic patients in the same population. Other diseases such as granulomatosiss with polyangiitis (formerly known as Wegener’s granulomatosis), rheumatoid arthritis, skin and soft tissue infections atopic dermatitis, and recurrent furunculosis have been related with an increased carriage rate.

In healthy subjects, found similar carriage rates in men and women, while men had higher bacterial density. Reports of a higher risk of nasal carriage of S. aureus among hospital workers than the rest of the population have not been confirmed. The association between smoking and nasal carriage seems also controversial. In a study by, active smoking in healthy adults was found to be a protective factor for carriage of S. aureus, with a hypothesized bactericidal activity of cigarette smokes. Conversely, a recent study showed that smokers were more frequently colonized than non-smokers, and cessation from smoking improved clearance of nasal S. aureus in an experimental inoculation study. Many other host conditions have been punctually studied and reported as additional predisposing factor such as hormonal contraception and presence of hemoglobin in nasal secretions.

At the genetic level, no correlation was found between genetic factors and S. aureus carriage. No significant heritability for S. aureus nasal colonization was detected in twins and family studies. Interestingly, some polymorphisms in host inflammatory response genes have been associated with S. aureus nasal carriage. The presence of the histocompatibility antigen phenotype HLA-DR3 could be a predisposition.

As previously said, at the immune system level, polymorphisms in genes encoding some proteins and differential expression profiles of AMPs could be the determinants of the various carriage states.

In a study involving 93 type 1 diabetes patients, vitamin D receptor polymorphisms were determined in Deoxyribonucleic acid (DNA) extracted from peripheral blood leukocytes. Analysis showed that presence of specific alleles coding for vitamin D receptors were associated with an increased rate of S. aureus colonization.

Nasal Carriage of S. aureus as a Risk Factor for Infections

Staphylococcus aureus nasal colonization has been identified as a major risk factor for the development of patent staphylococcal infections, weather community acquired, or nosocomial which increases the risk by 2 to 10 times. The risk of infection in nasal carriers has been mainly studied in surgical patients (general, orthopedic, cardiac, and neurosurgeries), patients on hemodialysis, patients on chronic ambulatory peritoneal dialysis (CAPD), HIV-infected patients, and intensive care unit patients. It has also been shown to be the primary risk factor for recurrent furunculosis, nasal colonization being present in almost 60% of individuals with furuncles and impetigo (Figure 2 and Table 3).

Surgical Site Infections

Developing a post-operative infection is a multifactorial process usually combining preoperative, intraoperative, and post-operative factors. Nasal colonization can actually be considered as a preoperative risk factor for MRSA and MSSA infections. S. aureus can spread from the anterior nares to other areas on the skin surface and thus contaminate the surgical wound during the operative procedure. It has been shown that around 80% of strains causing a staphylococcal infection at the site of surgery have molecular identity with S. aureus isolates in the nares of concerned patients.

Surgical site infections (SSI) are one of the most common post-operative complications and represent 20 to 30% of healthcare associated infections (HCAI). While enterobacteria and other uro-digestive bacteria are dominant in infections after gastrointestinal, urological and gynecological surgeries, S. aureus predominates in orthopedic and cardiac surgery settings. In orthopedic patients, biofilms can form on the implants leading to therapeutic challenges. According to the French Institute for Public Health Surveillance in 2014, S. aureus composed 19.4% of isolated germs in SSIs after coronary surgeries, 51.9% of organisms causing SSIs in orthopedic surgeries, and 29.3% of organisms causing infections in gynecologic obstetric surgery in 2014. Similar implications have been also found in other countries.

Several studies including case–control and multivariate analysis have identified nasal carriage of S. aureus an independent risk factor for SSIs. In the case–control study from, cardiac surgery patients were screened for their nasal carriage status the day before surgery and followed for the development of an SSI. S. aureus wound infections occurred in 40 patients as opposed to 120 controls who did not develop infection. Nasal carriage, identified in 52% of cases as compared to 12% of controls, was found to be a significant risk factor for the development of these post-operative infections with an OR = 9.6, 95% CI (3.9–23.7). In a study involving 357 patients undergoing major heart surgery, nasal carriers had a higher incidence of SSI than non-carriers (12.5% vs. 5%, P = 0.01). Similar conclusions were obtained for orthopedic patients with an incidence increasing from 3- to 11-fold.

Surgical site infections have an important impact on the patient and the healthcare system. These infections increase hospital stay, mortality and healthcare costs and decrease health-related quality of life. A retrospective database analysis in France concluded that staphylococcal infections led to approximately 1.0 and 1.4 additional hospitalizations per patient, 22.1 and 22.4 additional hospital days, and an excess cost of €15,475 and €13,389 after cardiothoracic and orthopedic surgeries respectively. The rate of in-hospital mortality was 2.6 times and six times higher among infected patients than non-infected patients in cardiothoracic and orthopedic procedures.

Methicillin-resistant S. aureus carriage could increase the risk for the development of SSIs. In a systematic review, patients colonized with MRSA were four times more likely to develop invasive infection than patients colonized with MSSA. MRSA infections are reported to cause up to 40% of HCAI worldwide with particularly high incidence in the United States and many European countries and have been shown to have increased morbi-mortality as compared to MSSA. In a study carried out by, patients with SSI due to MRSA had a 2.6 higher risk of dying within 3 months, the duration of hospital stay was 6 days longer, and the related cost was increased of $23,000 compared to patients with SSI due to MSSA. On the other hand, a meta-analysis of 31 cohort studies on S. aureus bacteremia, showed significantly higher mortality with MRSA than with MSSA. However, the reasons for increased fatality rate with MRSA infections are unclear. Some authors suggest that MRSA and MSSA bacteria are equally virulent but MRSA infections usually develop in patients previously treated with antibiotics. Thus, as previously suggested, the differences in patients’ fatality rate may rather reflect the severity of underlying conditions than a higher bacteria-related increased virulence.

Infections in Nonsurgical Patients

Nasal carriage of S. aureus has also been found to be a risk factor for subsequent infections in nonsurgical patients. screened 14,008 adults who had nasal swab on admission in a nonsurgical department, 3420 (24%) were positive for S. aureus. The follow-up identified 81 patients who developed S. aureus bacteremia between 2 and 120 days after swabbing, which was three times more frequent in carriers than in non-carriers. Interestingly, the death rate from S. aureus bacteremia was higher in non-carriers than carriers. This could be due to the protective immunity of anti-staphylococcal antibodies. Approximately, 80% of S. aureus blood isolates causing bacteremia were of endogenous origins and identical to those isolated from the anterior nares of corresponding patients, thus confirming previous report.

A prospective cohort study evaluated the occurrence of S. aureus infections in 5161 patients who were screened for nasal carriage when admitted to the ICU. ICU-associated S. aureus infections were defined by the development of infection >48 h after their admission to the unit. These infections occurred in 113 patients and nasal colonization was associated with a 2.5 to 4.7-fold increased risk.

In HIV-positive patients, a prospective cohort study evaluating 231 subjects every 3 months for a minimum of two years, has reported a 6% incidence of S. aureus infections, nasal carriers being more at risk [p = 0.04, OR = 3.6 (0.9–15.4)].

In hemodialysis and chronic peritoneal dialysis patients, most of infectious complications come from endogenous origin. S. aureus is the most common isolated agent from central venous catheter-related bacteremia, or exit-site infections of peritoneal dialysis catheters. Nasal carriers are at increased risk of contracting these infections.

Staphylococcus aureus is the most frequently isolated pathogen from diabetic foot infections. A study compared the genotypic profiles of S. aureus strains isolated from the nares and diabetic foot ulcer infections of 276 patients. The bacterium was isolated from both sites in 36% of the population, and identical strains were found in 65% of cases. Further investigations should be performed in order to confirm the benefit of screening and treating nasal carriers in this population.

Nasal carriage of S. aureus constitutes a risk factor for the development of skin and soft tissue infections caused by this germ in non-hospitalized and non-diseased subjects. It has been shown to be the primary risk factor for recurrent furunculosis. Nasal carriage is also a risk factor for secondary bacterial pneumonia in patients having influenza A virus infection. The viral infection causes host physiologic changes that generates the dissemination of S. aureus from nasal tissue to the lungs as demonstrated in a mouse model.

Perspectives

Nasal carriage of S. aureus is multifactorial and can predispose carriers to subsequent infections. Nasal decolonization of carriers is therefore recommended in patients undergoing cardiothoracic and orthopedic surgeries.

A full understanding of host-pathogen interactions can help find new decolonization strategies. New fields on colonization mechanisms should be investigated. For example, the role of mycobiota starts to be described in the pathophysiology of chronic respiratory diseases. Interaction of nasal S. aureus with the nasal fungal communities would be an interesting perspective to develop. On the other hand, some reports suggest that S. aureus can regulate host inflammatory gene expression. Epigenetics mechanisms could be interesting to investigate in order to better understand tolerance mechanisms in S. aureus colonization processes.

Author Contributions

AS wrote the review paper. FB, J-LM, OB, and J-MR corrected the manuscript. All authors approved and revised the final version of the manuscript.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 167

  1. 1.

    Andersen P. S. Pedersen J. K. Fode P. Skov R. L. Fowler V. G. Stegger M. (2012 ). Influence of host genetics and environment on nasal carriage of Staphylococcus aureus in danish middle-aged and elderly twins. J. Infect. Dis. 206 1178–1184.

    Not in our library10.1093/infdis/jis491

  2. 2.
    Clinical and Financial Outcomes Due to Methicillin Resistant Staphylococcus aureus Surgical Site Infection: A Multi-Center Matched Outcomes Study · 2009
    No notice
  3. 3.

    Archer N. K. Adappa N. D. Palmer J. N. Cohen N. A. Harro J. M. Lee S. K. (2016 ). Interleukin-17A (IL-17A) and IL-17F are critical for antimicrobial peptide production and clearance of Staphylococcus aureus nasal colonization. Infect. Immun. 84 3575–3583.

    Not in our library10.1128/iai.00596-16

  4. 4.

    Archer N. K. Harro J. M. Shirtliff M. E. (2013 ). Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx. Infect. Immun. 81 2070–2075.

    Not in our library10.1128/iai.00084-13

  5. 5.

    Armstrong-Esther C. A. (1976 ). Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann. Hum. Biol. 3 221–227.

    Not in our library10.1080/03014467600001381

  6. 6.

    Askarian F. Ajayi C. Hanssen A.-M. van Sorge N. M. Pettersen I. Diep D. B. (2016 ). The interaction between Staphylococcus aureus SdrD and desmoglein 1 is important for adhesion to host cells. Sci. Rep. 6:22134.

    Not in our library10.1038/srep22134

  7. 7.

    Baur S. Rautenberg M. Faulstich M. Faulstich M. Grau T. Severin Y. (2014 ). A nasal epithelial receptor for Staphylococcus aureus WTA governs adhesion to epithelial cells and modulates nasal colonization. PLoS Pathog. 10:e1004089.

    Not in our library10.1371/journal.ppat.1004089

  8. 8.

    Bode L. G. M. Kluytmans J. A. J. W. Wertheim H. F. L. Bogaers D. Vandenbroucke-Grauls C. M. J. E. Roosendaal R. (2010 ). Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N. Engl. J. Med. 362 9–17.

    Not in our library10.1056/nejmoa0808939

  9. 9.

    Brégeon F. Rolain J.-M. (2015 ). Le résistome pulmonaire. Méd. Sci. 31 947–950.

    Not in our library10.1051/medsci/20153111003

  10. 10.

    Breuer K. HAussler S. Kapp A. Werfel T. (2002 ). Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br. J. Dermatol. 147 55–61.

    Not in our library10.1046/j.1365-2133.2002.04872.x

  11. 11.
    Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design · 2014
    No notice
  12. 12.

    Burgey C. Kern W. V. Römer W. Rieg S. (2016 ). Differential induction of innate defense antimicrobial peptides in primary nasal epithelial cells upon stimulation with inflammatory cytokines, Th17 cytokines or bacterial conditioned medium from Staphylococcus aureus isolates. Microb. Pathog. 90 69–77.

    Not in our library10.1016/j.micpath.2015.11.023

  13. 13.

    Burian M. Wolz C. Goerke C. (2010 ). Regulatory adaptation of Staphylococcus aureus during nasal colonization of humans. PLoS One 5:e10040.

    Not in our library10.1371/journal.pone.0010040

  14. 14.

    Candi E. Schmidt R. Melino G. (2005 ). The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol. 6 328–340.

    Not in our library10.1038/nrm1619

  15. 15.
    Nasal colonization and bacterial contamination of mobile phones carried by medical staff in the operating room. · 2017
    Not checked
  16. 16.

    Chen A. F. Heyl A. E. Xu P. Z. Rao N. Klatt B. A. (2013 ). Preoperative decolonization effective at reducing staphylococcal colonization in total joint arthroplasty patients. J. Arthroplasty 28 18–20.

    Not in our library10.1016/j.arth.2013.03.036

  17. 17.

    Chen B. Dai X. He B. Pan K. Li H. Liu X. (2015 ). Differences in Staphylococcus aureus nasal carriage and molecular characteristics among community residents and healthcare workers at Sun Yat-sen University, Guangzhou, Southern China. BMC Infect. Dis. 15:303.

    Not in our library10.1186/s12879-015-1032-7

  18. 18.

    Chen B. J. Xie X. Y. Ni L. J. Dai X. L. Lu Y. Wu X. Q. (2017 ). Factors associated with Staphylococcus aureus nasal carriage and molecular characteristics among the general population at a Medical College Campus in Guangzhou, South China. Ann. Clin. Microbiol. Antimicrob. 16:28.

    Not in our library10.1186/s12941-017-0206-0

  19. 19.

    Chou Y.-H. Lee M.-S. Lin R.-Y. Wu C.-Y. (2015 ). Risk factors for methicillin-resistant Staphylococcus aureus skin and soft-tissue infections in outpatients in Taiwan. Epidemiol. Infect. 143 749–753.

    Not in our library10.1017/s0950268814001642

  20. 20.

    Clarke S. R. Brummell K. J. Horsburgh M. J. McDowell P. W. Mohamad S. A. S. Stapleton M. R. (2006 ). Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J. Infect. Dis. 193 1098–1108.

    Not in our library10.1086/501471

  21. 21.

    Clarke S. R. Wiltshire M. D. Foster S. J. (2004 ). IsdA of Staphylococcus aureus is a broad spectrum, iron-regulated adhesin. Mol. Microbiol. 51 1509–1519.

    Not in our library10.1111/j.1365-2958.2003.03938.x

  22. 22.

    Clement S. Vaudaux P. Francois P. Schrenzel J. Huggler E. Kampf S. (2005 ). Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J. Infect. Dis. 192 1023–1028.

    Not in our library10.1086/432735

  23. 23.

    Cole A. L. Muthukrishnan G. Chong C. Beavis A. Eade C. R. Wood M. P. (2016 ). Host innate inflammatory factors and staphylococcal protein A influence the duration of human Staphylococcus aureus nasal carriage. Mucosal Immunol. 9 1537–1548.

    Not in our library10.1038/mi.2016.2

  24. 24.

    Cole A. L. Schmidt-Owens M. Beavis A. C. Chong C. F. Tarwater P. M. Schaus J. (2018 ). Cessation from smoking improves innate host defense and clearance of experimentally inoculated nasal S. aureus. Infect. Immun. 86 e912–e917.

    Not in our library10.1128/iai.00912-17

  25. 25.

    Cole A. M. Dewan P. Ganz T. (1999 ). Innate antimicrobial activity of nasal secretions. Infect. Immun. 67 3267–3275.

    Not in our library10.1128/iai.67.7.3267-3275.1999

  26. 26.

    Colque-Navarro P. Jacobsson G. Andersson R. Flock J.-I. Möllby R. (2010 ). Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population. Clin. Vaccine Immunol. 17 1117–1123.

    Not in our library10.1128/cvi.00506-09

  27. 27.
    Surface proteins that promote adherence of Staphylococcus aureusto human desquamated nasal epithelial cells · 2009
    No notice
  28. 28.

    Cosgrove S. E. Sakoulas G. Perencevich E. N. Schwaber M. J. Karchmer A. W. Carmeli Y. (2003 ). Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin. Infect. Dis. 36 53–59.

    Not in our library10.1086/345476

  29. 29.

    Cunningham D. J. (1905 ). Cunningham’s Text-Book of Anatomy. New York, NY?: W. Wood and company.

    Not in our library

  30. 30.

    Dall’Antonia M. Coen P. G. Wilks M. Whiley A. Millar M. (2005 ). Competition between methicillin-sensitive and -resistant Staphylococcus aureus in the anterior nares. J. Hosp. Infect. 61 62–67.

    Not in our library10.1016/j.jhin.2005.01.008

  31. 31.

    De Jonge S. Atema J. J. Gans S. Boermeester M. A. Gomes S. M. Solomkin J. S. (2016 ). Surgical site infections 1 New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect. Dis. 16 e276–e287.

    Not in our library10.1016/s1473-3099(16)30398-x

  32. 32.

    Demos M. McLeod M. P. Nouri K. (2012 ). Recurrent furunculosis: a review of the literature. Br. J. Dermatol. 167 725–732.

    Not in our library10.1111/j.1365-2133.2012.11151.x

  33. 33.

    den Heijer C. D. van Bijnen E. M. Paget W. J. Pringle M. Goossens H. Bruggeman C. A. (2013 ). Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S. aureus, in nine European countries: a cross-sectional study. Lancet Infect. Dis. 13 409–415.

    Not in our library10.1016/s1473-3099(13)70036-7

  34. 34.

    Dunyach-Remy C. Courtais-Coulon C. DeMattei C. Jourdan N. Schuldiner S. Sultan A. (2017 ). Link between nasal carriage of Staphylococcus aureus and infected diabetic foot ulcers. Diabetes Metab. 43 167–171.

    Not in our library10.1016/j.diabet.2016.09.003

  35. 35.

    Durupt F. Mayor L. Bes M. Reverdy M.-E. Vandenesch F. Thomas L. (2007 ). Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. Br. J. Dermatol. 157 1161–1167.

    Not in our library10.1111/j.1365-2133.2007.08197.x

  36. 36.

    Eckhart L. Lippens S. Tschachler E. Declercq W. (2013 ). Cell death by cornification. Biochim. Biophys. Acta Mol. Cell Res. 1833 3471–3480.

    Not in our library10.1016/j.bbamcr.2013.06.010

  37. 37.

    Elie-Turenne M.-C. Fernandes H. Mediavilla J. R. Rosenthal M. Mathema B. Singh A. (2010 ). Prevalence and characteristics of Staphylococcus aureus colonization among healthcare professionals in an urban teaching hospital. Infect. Control Hosp. Epidemiol. 31 574–580.

    Not in our library10.1086/652525

  38. 38.

    Emonts M. Uitterlinden A. G. Nouwen J. L. Kardys I. Maat M. P. M. Melles D. C. (2008 ). Host polymorphisms in interleukin 4 complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J. Infect. Dis. 197 1244–1253.

    Not in our library10.1086/533501

  39. 39.

    Ena J. Boelaert J. R. Boyken L. D. Van Landuyt H. W. Godard C. A. Herwaldt L. A. (1994 ). Epidemiology of Staphylococcus aureus infections in patients on hemodialysis. Infect. Control Hosp. Epidemiol. 15 78–81.

    Not in our library10.2307/30145535

  40. 40.

    Eriksen N. H. Espersen F. Rosdahl V. T. Jensen K. (1995 ). Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol. Infect. 115 51–60.

    Not in our library10.1017/s0950268800058118

  41. 41.
    The Human Nasal Microbiota and Staphylococcus aureus Carriage · 2010
    No notice
  42. 42.

    Garrouste-Orgeas M. Timsit J. F. Kallel H. Ben Ali A. Dumay M. F. Paoli B. (2001 ). Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use. Infect. Control Hosp. Epidemiol. 22 687–692.

    Not in our library10.1086/501846

  43. 43.

    Ghasemzadeh-Moghaddam H. Neela V. van Wamel W. Hamat R. A. Shamsudin M. N. Hussin N. S. C. (2015 ). Nasal carriers are more likely to acquire exogenous Staphylococcus aureus strains than non-carriers. Clin. Microbiol. Infect. 21 998.e1–998.e7.

    Not in our library10.1016/j.cmi.2015.07.006

  44. 44.

    González-Zorn B. Senna J. P. M. Fiette L. Shorte S. Testard A. Chignard M. (2005 ). Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice. Infect. Immun. 73 1847–1851.

    Not in our library10.1128/iai.73.3.1847-1851.2005

  45. 45.

    Gorwitz R. J. Kruszon-Moran D. McAllister S. K. McQuillan G. McDougal L. K. Fosheim G. E. (2008 ). Changes in the prevalence of nasal colonization with Staphylococcus aureus in the united states, 2001–2004. J. Infect. Dis. 197 1226–1234.

    Not in our library10.1086/533494

  46. 46.

    Haill C. Fletcher S. Archer R. Jones G. Jayarajah M. Frame J. (2013 ). Prolonged outbreak of meticillin-resistant Staphylococcus aureus in a cardiac surgery unit linked to a single colonized healthcare worker. J. Hosp. Infect. 83 219–225.

    Not in our library10.1016/j.jhin.2012.11.019

  47. 47.

    Haim M. Trost A. Maier C. J. Achatz G. Feichtner S. Hintner H. (2010 ). Cytokeratin 8 interacts with clumping factor B: a new possible virulence factor target. Microbiology 156 3710–3721.

    Not in our library10.1099/mic.0.034413-0

  48. 48.
    Localization of Staphylococcus aureus in tissue from the nasal vestibule in healthy carriers · 2017
    Not checked
  49. 49.

    Harbarth S. Liassine N. Dharan S. Herrault P. Auckenthaler R. Pittet D. (2000 ). Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 31 1380–1385.

    Not in our library10.1086/317484

  50. 50.

    Hayes S. M. Howlin R. Johnston D. A. Webb J. S. Clarke S. C. Stoodley P. (2015 ). Intracellular residency of Staphylococcus aureus within mast cells in nasal polyps: a novel observation. J. Allergy Clin. Immunol. 135 1648–1651.e5.

    Not in our library10.1016/j.jaci.2014.12.1929

  51. 51.

    Holtfreter S. Roschack K. Eichler P. Eske K. Holtfreter B. Kohler C. (2006 ). Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J. Infect. Dis. 193 1275–1278.

    Not in our library10.1086/503048

  52. 52.

    Honda H. Krauss M. J. Coopersmith C. M. Kollef M. H. Richmond A. M. Fraser V. J. (2010 ). Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter? Infect. Control Hosp. Epidemiol. 31 584–591.

    Not in our library10.1086/652530

  53. 53.

    Hraiech S. Roch A. Lepidi H. Atieh T. Audoly G. Rolain J.-M. (2013 ). Impaired virulence and fitness of a colistin-resistant clinical isolate of Acinetobacter baumannii in a rat model of pneumonia. Antimicrob. Agents Chemother. 57 5120–5121.

    Not in our library10.1128/aac.00700-13

  54. 54.

    Human Microbiome Project Consortium (2012 ). Structure, function and diversity of the healthy human microbiome. Nature 486 207–214.

    Not in our library10.1038/nature11234

  55. 55.

    Humphreys H. (2012 ). Staphylococcus aureus: the enduring pathogen in surgery. Surgeon 10 357–360.

    Not in our library10.1016/j.surge.2012.05.003

  56. 56.

    Immergluck L. Jain S. Ray S. Mayberry R. Satola S. Parker T. (2017 ). Risk of skin and soft tissue infections among children found to be Staphylococcus aureus MRSA USA300 carriers. West. J. Emerg. Med. 18 201–212.

    Not in our library10.5811/westjem.2016.10.30483

  57. 57.

    Iwase T. Uehara Y. Shinji H. Tajima A. Seo H. Takada K. (2010 ). Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465 346–349.

    Not in our library10.1038/nature09074

  58. 58.

    Kalmeijer M. D. van Nieuwland-Bollen E. Bogaers-Hofman D. de Baere G. A. (2000 ). Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect. Control Hosp. Epidemiol. 21 319–323.

    Not in our library10.1086/501763

  59. 59.

    Kaspar U. Kriegeskorte A. Schubert T. Peters G. Rudack C. Pieper D. H. (2016 ). The culturome of the human nose habitats reveals individual bacterial fingerprint patterns. Environ. Microbiol. 18 2130–2142.

    Not in our library10.1111/1462-2920.12891

  60. 60.

    Katneni R. Hedayati S. S. (2007 ). Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management. Nat. Clin. Pract. Nephrol. 3 256–266.

    Not in our library10.1038/ncpneph0447

  61. 61.

    Kinsman O. S. Mckenna R. Noble W. C. (1983 ). Association between histocompatability antigens (HLA) and nasal carriage of Staphylococcus aureus. J. Med. Microbiol. 16 215–220.

    Not in our library10.1099/00222615-16-2-215

  62. 62.

    Klevens R. M. Edwards J. R. Richards C. L. Horan T. C. Gaynes R. P. Pollock D. A. (2007 ). Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 122 160–166.

    Not in our library10.1177/003335490712200205

  63. 63.

    Kluytmans J. van Belkum A. Verbrugh H. (1997 ). Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10 505–520.

    Not in our library10.1128/cmr.10.3.505

  64. 64.

    Kluytmans J. A. Mouton J. W. Ijzerman E. P. Vandenbroucke-Grauls C. M. Maat A. W. Wagenvoort J. H. (1995 ). Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J. Infect. Dis. 171 216–219.

    Not in our library10.1093/infdis/171.1.216

  65. 65.

    Kluytmans J. A. J. W. Manders M.-J. van Bommel E. Verbrugh H. (1996 ). Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect. Control Hosp. Epidemiol. 17 793–797.

    Not in our library10.2307/30141172

  66. 66.

    Kotpal R. S K. P. Bhalla P. Dewan R. Kaur R. (2016 ). Incidence and risk factors of nasal carriage of Staphylococcus aureus in HIV-infected individuals in comparison to HIV-uninfected individuals: a case–control study. J. Int. Assoc. Provid. AIDS Care 15 141–147.

    Not in our library10.1177/2325957414554005

  67. 67.

    Krismer B. Weidenmaier C. Zipperer A. Peschel A. (2017 ). The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat. Rev. Microbiol. 15 675–687.

    Not in our library10.1038/nrmicro.2017.104

  68. 68.

    Lamanna O. Bongiorno D. Bertoncello L. Grandesso S. Mazzucato S. Pozzan G. B. (2017 ). Rapid containment of nosocomial transmission of a rare community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) clone, responsible for the Staphylococcal Scalded Skin Syndrome (SSSS). Ital. J. Pediatr. 43:5.

    Not in our library10.1186/s13052-016-0323-y

  69. 69.

    Lamarsalle L. Hunt B. Schauf M. Szwarcensztein K. Valentine W. J. (2013 ). Evaluating the clinical and economic burden of healthcare-associated infections during hospitalization for surgery in France. Epidemiol. Infect. 141 2473–2482.

    Not in our library10.1017/s0950268813000253

  70. 70.

    Laudien M. Gadola S. D. Podschun R. Hedderich J. Paulsen J. Reinhold-Keller E. (2010 ). Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal polyps. Clin. Exp. Rheumatol. 28 51–55.

    Not in our library

  71. 71.

    >Le Réseau d’alerte d’investigation et de surveillance des infections nosocomiales (Raisin) (2015 ). Surveillance des Infections du Site Opératoire, France 2013. France: Institut de veille sanitaire.

    Not in our library

  72. 72.

    Leaper D. J. van Goor H. Reilly J. Petrosillo N. Geiss H. K. Torres A. J. (2004 ). Surgical site infection - a European perspective of incidence and economic burden. Int. Wound J. 1 247–273.

    Not in our library10.1111/j.1742-4801.2004.00067.x

  73. 73.

    Lehar S. M. Pillow T. Xu M. Staben L. Kajihara K. K. Vandlen R. (2015 ). Novel antibody–antibiotic conjugate eliminates intracellular S. aureus. Nature 527 323–328.

    Not in our library10.1038/nature16057

  74. 74.

    Lepelletier D. Perron S. Bizouarn P. Caillon J. Drugeon H. Michaud J.-L. (2005 ). Surgical-site infection after cardiac surgery: incidence, microbiology, and risk factors. Infect. Control Hosp. Epidemiol. 26 466–472.

    Not in our library10.1086/502569

  75. 75.

    Leshem E. Maayan-Metzger A. Rahav G. Dolitzki M. Kuint J. Roytman Y. (2012 ). Transmission of Staphylococcus aureus from mothers to newborns. Pediatr. Infect. Dis. J. 31 360–363.

    Not in our library10.1097/inf.0b013e318244020e

  76. 76.

    Lina G. Boutite F. Tristan A. Bes M. Etienne J. Vandenesch F. (2003 ). Bacterial competition for human nasal cavity colonization: role of Staphylococcal agr alleles. Appl. Environ. Microbiol. 69 18–23.

    Not in our library10.1128/aem.69.1.18-23.2003

  77. 77.

    Liu C. M. Price L. B. Hungate B. A. Abraham A. G. Larsen L. A. Christensen K. (2015 ). Staphylococcus aureus and the ecology of the nasal microbiome. Sci. Adv. 1:e1400216.

    Not in our library10.1126/sciadv.1400216

  78. 78.

    Liu Q. Du X. Hong X. Li T. Zheng B. He L. (2015 ). Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection. Infect. Immun. 83 2168–2174.

    Not in our library10.1128/iai.02951-14

  79. 79.

    Luzar M. A. Coles G. A. Faller B. Slingeneyer A. Dah G. D. Briat C. (1990 ). Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N. Engl. J. Med. 322 505–509.

    Not in our library10.1056/nejm199002223220804

  80. 80.
    Clinical evaluation of early acquisition of Staphylococcus aureus carriage by newborns · 2017
    Not checked
  81. 81.

    Magill S. S. Hellinger W. Cohen J. Kay R. Bailey C. Boland B. (2012 ). Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida. Infect. Control Hosp. Epidemiol. 33 283–291.

    Not in our library10.1086/664048

  82. 82.

    McKinnell J. A. Huang S. S. Eells S. J. Cui E. Miller L. G. (2013 ). Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. Infect. Control Hosp. Epidemiol. 34 161–170.

    Not in our library10.1086/669095

  83. 83.

    Miller L. G. Eells S. J. Taylor A. R. David M. Z. Ortiz N. Zychowski D. (2012 ). Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology. Clin. Infect. Dis. 54 1523–1535.

    Not in our library10.1093/cid/cis213

  84. 84.

    Modak R. Das Mitra S. Vasudevan M. Krishnamoorthy P. Kumar M. Bhat A. V (2014 ). Epigenetic response in mice mastitis: role of histone H3 acetylation and microRNA(s) in the regulation of host inflammatory gene expression during Staphylococcus aureus infection. Clin. Epigenetics 6:12.

    Not in our library10.1186/1868-7083-6-12

  85. 85.
    Nasal Colonisation by Staphylococcus aureus Depends upon Clumping Factor B Binding to the Squamous Epithelial Cell Envelope Protein Loricrin · 2012
    No notice
  86. 86.

    Mulcahy M. E. Leech J. M. Renauld J.-C. Mills K. H. McLoughlin R. M. (2016 ). Interleukin-22 regulates antimicrobial peptide expression and keratinocyte differentiation to control Staphylococcus aureus colonization of the nasal mucosa. Mucosal Immunol. 9 1429–1441.

    Not in our library10.1038/mi.2016.24

  87. 87.

    Mulcahy M. E. McLoughlin R. M. (2016 ). Host–bacterial crosstalk determines Staphylococcus aureus nasal colonization. Trends Microbiol. 24 872–886.

    Not in our library10.1016/j.tim.2016.06.012

  88. 88.

    Muñoz P. Hortal J. Giannella M. Barrio J. M. Rodríguez-Créixems M. Pérez M. J. (2008 ). Nasal carriage of S. aureus increases the risk of surgical site infection after major heart surgery. J. Hosp. Infect. 68 25–31.

    Not in our library10.1016/j.jhin.2007.08.010

  89. 89.

    Muthukrishnan G. Lamers R. P. Ellis A. Paramanandam V. Persaud A. B. Tafur S. (2013 ). Longitudinal genetic analyses of Staphylococcus aureus nasal carriage dynamics in a diverse population. BMC Infect. Dis. 13:221.

    Not in our library10.1186/1471-2334-13-221

  90. 90.

    Nardi G. Di Silvestre A. D. De Monte A. Massarutti D. Proietti A. Grazia Troncon M. (2001 ). Reduction in gram-positive pneumonia and antibiotic consumption following the use of a SDD protocol including nasal and oral mupirocin. Eur. J. Emerg. Med. 8 203–214.

    Not in our library10.1097/00063110-200109000-00008

  91. 91.

    Negi V. Pal S. Juyal D. Sharma M. K. Sharma N. (2015 ). Bacteriological profile of surgical site infections and their antibiogram: a study from resource constrained rural setting of uttarakhand state, India. J. Clin. Diagn. Res. 9 DC17–DC20.

    Not in our library10.7860/jcdr/2015/15342.6698

  92. 92.

    Nguyen M. H. Kauffman C. A. Goodman R. P. Squier C. Arbeit R. D. Singh N. (1999 ). Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann. Intern. Med. 130 221–225.

    Not in our library10.7326/0003-4819-130-3-199902020-00026

  93. 93.

    NICE Clinical Guidelines (2008 ). National Collaborating Centre for Women’s and Children’s Health (UK). Preoperative phase, Surgical Site Infection: Prevention and Treatment of Surgical Site Infection. London: National Institute for Health and Clinical Excellence.

    Not in our library

  94. 94.

    Nilsson A. C. Janson H. Wold H. Fugelli A. Andersson K. Håkangård C. (2015 ). LTX-109 is a novel agent for nasal decolonization of methicillin-resistant and -sensitive Staphylococcus aureus. Antimicrob. Agents Chemother. 59 145–151.

    Not in our library10.1128/aac.03513-14

  95. 95.

    Nouwen J. Schouten J. Schneebergen P. Snijders S. Maaskant J. Koolen M. (2006 ). Staphylococcus aureus carriage patterns and the risk of infections associated with continuous peritoneal dialysis. J. Clin. Microbiol. 44 2233–2236.

    Not in our library10.1128/jcm.02083-05

  96. 96.

    Nouwen J. L. Fieren M. W. J. A. Snijders S. Verbrugh H. A. Van Belkum A. (2005 ). Persistent (not intermittent) nasal carriage ofStaphylococcus aureus is the determinant of CPD-related infections. Kidney Int. 67 1084–1092.

    Not in our library10.1111/j.1523-1755.2005.00174.x

  97. 97.

    Nouwen J. L. Optima Grafische Communicatie (2004 ). Determinants, Risks & Dynamics of Staphylococcus aureus Nasal Carriage. Doctoral thesis, Erasmus University Rotterdam Rotterdam.

    Not in our library

  98. 98.

    Nouwen J. L. Ott A. Kluytmans-Vandenbergh M. F. Q. Boelens H. A. M. Hofman A. van Belkum A. (2004 ). Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a “culture rule”. Clin. Infect. Dis. 39 806–811.

    Not in our library10.1086/423376

  99. 99.

    Nurjadi D. Heeg K. Weber A. N. R. Zanger P. (2018 ). Toll-like receptor (TLR) -9 promotor polymorphisms and gene expression are associated with persistent Staphylococcus aureus nasal carriage. Clin. Microbiol. Infect. [Epub ahead of print].

    Not in our library10.1016/j.cmi.2018.02.014

  100. 100.

    Nurjadi D. Kain M. Marcinek P. Gaile M. Heeg K. Zanger P. (2016 ). Ratio of T-helper type 1 (Th1) to Th17 cytokines in whole blood is associated with human β-defensin 3 expression in skin and persistent Staphylococcus aureus nasal carriage. J. Infect. Dis. 214 1744–1751.

    Not in our library10.1093/infdis/jiw440

  101. 101.

    O’Brien L. M. Walsh E. J. Massey R. C. Peacock S. J. Foster T. J. (2002 ). Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell. Microbiol. 4 759–770.

    Not in our library10.1046/j.1462-5822.2002.00231.x

  102. 102.

    Olsen K. Danielsen K. Wilsgaard T. Sangvik M. Sollid J. U. E. Thune I. (2013 ). Obesity and Staphylococcus aureus nasal colonization among women and men in a general population. PLoS One 8:e63716.

    Not in our library10.1371/journal.pone.0063716

  103. 103.

    Olsen K. Falch B. M. Danielsen K. Johannessen M. Ericson Sollid J. U. Thune I. (2012 ). Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromsø Staph and Skin Study. Eur. J. Clin. Microbiol. Infect. Dis. 31 465–473.

    Not in our library10.1007/s10096-011-1331-x

  104. 104.

    Ong L. M. Ch’ng C. C. Wee H. C. Supramaniam P. Zainal H. Goh B. L. (2017 ). Risk of peritoneal dialysis-related peritonitis in a multi-racial asian population. Perit. Dial. Int. 37 35–43.

    Not in our library10.3747/pdi.2015.00141

  105. 105.

    Ou J. Bassiouni A. Drilling A. Psaltis A. J. Vreugde S. Wormald P. J. (2017 ). The persistence of intracellular Staphylococcus aureus in the sinuses: a longitudinal study. Rhinol. J. 55 305–311.

    Not in our library10.4193/rhin16.218

  106. 106.

    Ou J. Drilling A. Singhal D. Tan N. C.-W. Wallis-Hill D. Vreugde S. (2016 ). Association of intracellular Staphylococcus aureus with prognosis in chronic rhinosinusitis. Int. Forum Allergy Rhinol. 6 792–799.

    Not in our library10.1002/alr.21758

  107. 107.

    Panierakis C. Goulielmos G. Mamoulakis D. Maraki S. Papavasiliou E. Galanakis E. (2009 ). Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 1 diabetes. Int. J. Infect. Dis. 13 e437–e443.

    Not in our library10.1016/j.ijid.2009.02.012

  108. 108.

    Peacock S. J. de Silva I. Lowy F. D. (2001 ). What determines nasal carriage of Staphylococcus aureus? Trends Microbiol. 9 605–610.

    Not in our library10.1016/s0966-842x(01)02254-5

  109. 109.

    Peacock S. J. Justice A. Griffiths D. de Silva G. D. I. Kantzanou M. N. Crook D. (2003 ). Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J. Clin. Microbiol. 41 5718–5725.

    Not in our library10.1128/jcm.41.12.5718-5725.2003

  110. 110.

    Perkins S. Walsh E. J. Deivanayagam C. C. Narayana S. V Foster T. J. Höök M. (2001 ). Structural organization of the fibrinogen-binding region of the clumping factor B MSCRAMM of Staphylococcus aureus. J. Biol. Chem. 276 44721–44728.

    Not in our library10.1074/jbc.m106741200

  111. 111.

    Perl T. M. Cullen J. J. Wenzel R. P. Zimmerman M. B. Pfaller M. A. Sheppard D. (2002 ). Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N. Engl. J. Med. 346 1871–1877.

    Not in our library10.1056/nejmoa003069

  112. 112.

    Perl T. M. Golub J. E. (1998 ). New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann. Pharmacother. 32 S7–S16.

    Not in our library10.1177/106002809803200104

  113. 113.

    Peschel A. Sahl H.-G. (2006 ). The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4 529–536.

    Not in our library10.1038/nrmicro1441

  114. 114.

    Plouin-Gaudon I. Clement S. Huggler E. Chaponnier C. François P. Lew D. (2006 ). Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis. Rhinology 44 249–254.

    Not in our library

  115. 115.

    Pournajaf A. Ardebili A. Goudarzi L. Khodabandeh M. Narimani T. Abbaszadeh H. (2014 ). PCR-based identification of methicillin-resistant Staphylococcus aureus strains and their antibiotic resistance profiles. Asian Pac. J. Trop. Biomed. 4 S293–S297.

    Not in our library10.12980/apjtb.4.2014c423

  116. 116.
    Transmission of Staphylococcus aureus between health-care workers, the environment, and patients in an intensive care unit: a longitudinal cohort study based on whole-genome sequencing · 2017
    No notice
  117. 117.

    Pynnonen M. Stephenson R. E. Schwartz K. Hernandez M. Boles B. R. (2011 ). Hemoglobin promotes Staphylococcus aureus nasal colonization. PLoS Pathog. 7:e1002104.

    Not in our library10.1371/journal.ppat.1002104

  118. 118.

    Quinn G. A. Cole A. M. (2007 ). Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology 122 80–89.

    Not in our library10.1111/j.1365-2567.2007.02615.x

  119. 119.

    Raviglione M. C. Mariuz P. Pablos-Mendez A. Battan R. Ottuso P. Taranta A. (1990 ). High Staphylococcus aureus nasal carriage rate in patients with acquired immunodeficiency syndrome or AIDS-related complex. Am. J. Infect. Control 18 64–69.

    Not in our library10.1016/0196-6553(90)90083-5

  120. 120.

    Reagan D. R. Doebbeling B. N. Pfaller M. A. Sheetz C. T. Houston A. K. Hollis R. J. (1991 ). Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann. Intern. Med. 114 101–106.

    Not in our library10.7326/0003-4819-114-2-101

  121. 121.

    Reddinger R. M. Luke-Marshall N. R. Hakansson A. P. Campagnari A. A. (2016 ). Host physiologic changes induced by influenza a virus lead to Staphylococcus aureus biofilm dispersion and transition from asymptomatic colonization to invasive disease. mBio 7:e01235-16.

    Not in our library10.1128/mbio.01235-16

  122. 122.

    Regev-Yochay G. Trzcinski K. Thompson C. M. Malley R. Lipsitch M. (2006 ). Interference between Streptococcus pneumoniae and Staphylococcus aureus: in vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J. Bacteriol. 188 4996–5001.

    Not in our library10.1128/jb.00317-06

  123. 123.

    Rigaill J. Morgene M. F. Gavid M. Lelonge Y. He Z. Carricajo A. (2018 ). Intracellular activity of antimicrobial compounds used for Staphylococcus aureus nasal decolonization. J. Antimicrob. Chemother. [Epub ahead of print].

    Not in our library10.1093/jac/dky318

  124. 124.

    Roche F. M. Meehan M. Foster T. J. (2003 ). The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiology 149 2759–2767.

    Not in our library10.1099/mic.0.26412-0

  125. 125.

    Roghmann M.-C. Johnson J. K. Stine O. C. Lydecker A. D. Ryan K. A. Mitchell B. D. (2011 ). Persistent Staphylococcus aureus colonization is not a strongly heritable trait in Amish families. PLoS One 6:e17368.

    Not in our library10.1371/journal.pone.0017368

  126. 126.

    Ruimy R. Angebault C. Djossou F. Dupont C. Epelboin L. Jarraud S. (2010 ). Are host genetics the predominant determinant of persistent nasal Staphylococcus aureus carriage in humans? J. Infect. Dis. 202 924–934.

    Not in our library10.1086/655901

  127. 127.

    Saadatian-Elahi M. Teyssou R. Vanhems P. (2008 ). Staphylococcus aureus, the major pathogen in orthopaedic and cardiac surgical site infections: a literature review. Int. J. Surg. 6 238–245.

    Not in our library10.1016/j.ijsu.2007.05.001

  128. 128.

    Saadatian-Elahi M. Tristan A. Laurent F. Rasigade J.-P. Bouchiat C. Ranc A.-G. (2013 ). Basic rules of hygiene protect health care and lab workers from nasal colonization by Staphylococcus aureus: an international cross-sectional study. PLoS One 8:e82851.

    Not in our library10.1371/journal.pone.0082851

  129. 129.

    Safdar N. Bradley E. A. (2008 ). The risk of infection after nasal colonization with Staphylococcus aureus. Am. J. Med. 121 310–315.

    Not in our library10.1016/j.amjmed.2007.07.034

  130. 130.

    Savage J. W. Anderson P. A. (2013 ). An update on modifiable factors to reduce the risk of surgical site infections. Spine J. 13 1017–1029.

    Not in our library10.1016/j.spinee.2013.03.051

  131. 131.

    Schaffer A. C. Solinga R. M. Cocchiaro J. Portoles M. Kiser K. B. Risley A. (2006 ). Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model. Infect. Immun. 74 2145–2153.

    Not in our library10.1128/iai.74.4.2145-2153.2006

  132. 132.

    Schmidt A. Bénard S. Cyr S. (2015 ). Hospital cost of staphylococcal infection after cardiothoracic or orthopedic operations in France: a retrospective database analysis. Surg. Infect. 16 428–435.

    Not in our library10.1089/sur.2014.045

  133. 133.

    Selva L. Viana D. Regev-Yochay G. Trzcinski K. Corpa J. M. Lasa I. (2009 ). Killing niche competitors by remote-control bacteriophage induction. Proc. Natl. Acad. Sci. U.S.A. 106 1234–1238.

    Not in our library10.1073/pnas.0809600106

  134. 134.

    Sherertz R. J. Reagan D. R. Hampton K. D. Robertson K. L. Streed S. A. Hoen H. M. (1996 ). A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann. Intern. Med. 124 539–547.

    Not in our library10.7326/0003-4819-124-6-199603150-00001

  135. 135.

    Sissolak D. Geusau A. Heinze G. Witte W. Rotter M. L. (2002 ). Risk factors for nasal carriage of Staphylococcus aureus in infectious disease patients, including patients infected with HIV, and molecular typing of colonizing strains. Eur. J. Clin. Microbiol. Infect. Dis. 21 88–96.

    Not in our library10.1007/s10096-001-0666-0

  136. 136.

    Sivaraman K. Venkataraman N. Cole A. M. (2009 ). Staphylococcus aureus nasal carriage and its contributing factors. Future Microbiol. 4 999–1008.

    Not in our library10.2217/fmb.09.79

  137. 137.

    Steinert P. M. Marekov L. N. (1995 ). The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J. Biol. Chem. 270 17702–17711.

    Not in our library10.1074/jbc.270.30.17702

  138. 138.

    Sugimoto S. Iwamoto T. Takada K. Okuda K.-I. Tajima A. Iwase T. (2013 ). Staphylococcus epidermidis Esp degrades specific proteins associated with Staphylococcus aureus biofilm formation and host-pathogen interaction. J. Bacteriol. 195 1645–1655.

    Not in our library10.1128/jb.01672-12

  139. 139.

    Tan N. C.-W. Cooksley C. M. Roscioli E. Drilling A. J. Douglas R. Wormald P.-J. (2014 ). Small-colony variants and phenotype switching of intracellular Staphylococcus aureus in chronic rhinosinusitis. Allergy 69 1364–1371.

    Not in our library10.1111/all.12457

  140. 140.

    Trautman M. Stecher J. Luz K. Hemmer W. Hupp T. Grützner P. A. (2007 ). The use of mupirocin in the eradication of Staphylococcus aureus. Dtsch. Arztebl. 104:A-3259.

    Not in our library

  141. 141.

    Uehara Y. Nakama H. Agematsu K. Uchida M. Kawakami Y. Abdul Fattah A. S. M. (2000 ). Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp. J. Hosp. Infect. 44 127–133.

    Not in our library10.1053/jhin.1999.0680

  142. 142.

    van Belkum A. Verkaik N. J. de Vogel C. P. Boelens H. A. Verveer J. Nouwen J. L. (2009 ). Reclassification of Staphylococcus aureus nasal carriage types. J. Infect. Dis. 199 1820–1826.

    Not in our library10.1086/599119

  143. 143.

    van den Akker E. L. T. Nouwen J. L. Melles D. C. van Rossum E. F. C. Koper J. W. Uitterlinden A. G. (2006 ). Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J. Infect. Dis. 194 814–818.

    Not in our library10.1086/506367

  144. 144.

    VandenBergh M. F. Yzerman E. P. van Belkum A. Boelens H. A. Sijmons M. Verbrugh H. A. (1999 ). Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J. Clin. Microbiol. 37 3133–3140.

    Not in our library10.1128/jcm.37.10.3133-3140.1999

  145. 145.

    Verhoeven P. O. Grattard F. Carricajo A. Lucht F. Cazorla C. Garraud O. (2012 ). An algorithm based on one or two nasal samples is accurate to identify persistent nasal carriers of Staphylococcus aureus. Clin. Microbiol. Infect. 18 551–557.

    Not in our library10.1111/j.1469-0691.2011.03611.x

  146. 146.

    Von Eiff C. Becker K. Machka K. Stammer H. Peters G. (2001 ). Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N. Engl. J. Med. 344 11–16.

    Not in our library10.1056/nejm200101043440102

  147. 147.

    Vonberg R.-P. Stamm-Balderjahn S. Hansen S. Zuschneid I. Rüden H. Behnke M. (2006 ). How often do asymptomatic healthcare workers cause methicillin-resistant Staphylococcus aureus outbreaks? A systematic evaluation. Infect. Control Hosp. Epidemiol. 27 1123–1127.

    Not in our library10.1086/507922

  148. 148.

    Vuyk H. D. Watts S. J. (2006 ). “Nasal reconstruction,” in Facial Plastic and Reconstructive Surgery Vuyk H. D. Lohuis P. J. F. M. (London: Hodder Arnold) 455–480.

    Not in our library

  149. 149.

    Walsh T. L. Querry A. M. McCool S. Galdys A. L. Shutt K. A. Saul M. I. (2017 ). Risk factors for surgical site infections following neurosurgical spinal fusion operations: a case control study. Infect. Control Hosp. Epidemiol. 38 340–347.

    Not in our library10.1017/ice.2016.307

  150. 150.

    Wang J.-T. Chang S.-C. Ko W.-J. Chang Y.-Y. Chen M.-L. Pan H.-J. (2001 ). A hospital-acquired outbreak of methicillin-resistant Staphylococcus aureus infection initiated by a surgeon carrier. J. Hosp. Infect. 47 104–109.

    Not in our library10.1053/jhin.2000.0878

  151. 151.
    Utilizing Moist or Dry Swabs for the Sampling of Nasal MRSA Carriers? An In Vivo and In Vitro Study. · 2016
    Not checked
  152. 152.

    Weidenmaier C. Goerke C. Wolz C. (2012 ). Staphylococcus aureus determinants for nasal colonization. Trends Microbiol. 20 243–250.

    Not in our library10.1016/j.tim.2012.03.004

  153. 153.

    Weidenmaier C. Kokai-Kun J. F. Kristian S. A. Chanturiya T. Kalbacher H. Gross M. (2004 ). Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med. 10 243–245.

    Not in our library10.1038/nm991

  154. 154.

    Weidenmaier C. Kokai-Kun J. F. Kulauzovic E. Kohler T. Thumm G. Stoll H. (2008 ). Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int. J. Med. Microbiol. 298 505–513.

    Not in our library10.1016/j.ijmm.2007.11.006

  155. 155.

    Weinke T. Schiller R. Fehrenbach F. J. Pohle H. D. (1992 ). Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur. J. Clin. Microbiol. Infect. Dis. 11 985–989.

    Not in our library10.1007/bf01967787

  156. 156.

    Weiser M. C. Moucha C. S. (2015 ). The current state of screening and decolonization for the prevention of Staphylococcus aureus surgical site infection after total hip and knee arthroplasty. J. Bone Joint Surg. Am. 97 1449–1458.

    Not in our library10.2106/jbjs.n.01114

  157. 157.

    Wertheim H. F. L. Melles D. C. Vos M. C. van Leeuwen W. van Belkum A. Verbrugh H. A. (2005a ). The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5 751–762.

    Not in our library10.1016/s1473-3099(05)70295-4

  158. 158.

    Wertheim H. F. L. Verveer J. Boelens H. A. M. van Belkum A. Verbrugh H. A. Vos M. C. (2005b ). Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrob. Agents Chemother. 49 1465–1467.

    Not in our library10.1128/aac.49.4.1465-1467.2005

  159. 159.

    Wertheim H. F. L. van Kleef M. Vos M. C. Ott A. Verbrugh H. A. Fokkens W. (2006 ). Nose picking and nasal carriage of Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 27 863–867.

    Not in our library10.1086/506401

  160. 160.

    Wertheim H. F. L. Vos M. C. Ott A. van Belkum A. Voss A. Kluytmans J. A. J. W. (2004 ). Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364 703–705.

    Not in our library10.1016/s0140-6736(04)16897-9

  161. 161.
    Key Role for Clumping Factor B in Staphylococcus aureus Nasal Colonization of Humans · 2008
    No notice
  162. 162.

    Williams R. E. (1963 ). Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol. Rev. 27 56–71.

    Not in our library10.1128/br.27.1.56-71.1963

  163. 163.
    <italic toggle="yes">Propionibacterium</italic>-Produced Coproporphyrin III Induces <named-content content-type="genus-species">Staphylococcus aureus</named-content> Aggregation and Biofilm Formation · 2014
    Not checked
  164. 164.

    Yan M. Pamp S. J. Fukuyama J. Hwang P. H. Cho D.-Y. Holmes S. (2013 ). Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage. Cell Host Microbe 14 631–640.

    Not in our library10.1016/j.chom.2013.11.005

  165. 165.

    Yano M. Doki Y. Inoue M. Tsujinaka T. Shiozaki H. Monden M. (2000 ). Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery. Surg. Today 30 16–21.

    Not in our library10.1007/pl00010040

  166. 166.

    Zanger P. Nurjadi D. Gaile M. Gabrysch S. Kremsner P. G. (2012 ). Hormonal contraceptive use and persistent Staphylococcus aureus nasal carriage. Clin. Infect. Dis. 55 1625–1632.

    Not in our library10.1093/cid/cis778

  167. 167.

    Zipperer A. Konnerth M. C. Laux C. Berscheid A. Janek D. Weidenmaier C. (2016 ). Human commensals producing a novel antibiotic impair pathogen colonization. Nature 535 511–516.

    Not in our library10.1038/nature18634

Cited by papers we hold 8

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.